ABL Bio
298380.KQ
26.58 USD
-0.67
-2.46%
a
Overview
Last close
26.58 usd
Market cap
1.28B usd
52 week high
32.54 usd
52 week low
11.47 usd
Target price
34.19 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
57.4563
Price/Book Value
10.5604
Enterprise Value
1.24B usd
EV/Revenue
54.7747
EV/EBITDA
-32.1061
Key financials
Revenue TTM
22.67M usd
Gross Profit TTM
22.63M usd
EBITDA TTM
-33.67M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
185.47M usd
Net debt
N/A usd
About
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam-si, South Korea.
- Symbol298380.KQ
- ExchangeKQ
- IsinKR7298380007
- CountrySouth Korea
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Sang Hoon Lee Ph.D.
- HeadquarterSeongnam-si
- Web sitehttps://www.ablbio.com
